Clinical Pharmacokinetics

Duloxetine: Clinical Pharmacokinetics and Drug Interactions
pp. 281-294(14)
Authors: >Mary Pat Knadler,; Lobo, Evelyn; Chappell, Jill; Bergstrom, Richard

Pharmacokinetics and Pharmacodynamics of Pegfilgrastim
pp. 295-306(12)
Authors: Yang, Bing-Bing; Kido, Anna

Towards a Better Prediction of Peak Concentration, Volume of Distribution and Half-Life after Oral Drug Administration in Man, Using Allometry
pp. 307-318(12)
Authors: Sinha, Vikash K.; Vaarties, Karin; De Buck, Stefan S.; Fenu, Luca. A.; Nijsen, Marjoleen; Gilissen, Ron A.H.J.; Sanderson, Wendy; >Kelly Van Uytsel,; Hoeben, Eva; >Achiel Van Peer,; Mackie, Claire E.; Smit, Johan W.

Sex Differences in 3,4-Methylenedioxymethamphetamine (MDMA; Ecstasy)-Induced Cytochrome P450 2D6 Inhibition in Humans
pp. 319-329(11)
Authors: Yubero-Lahoz, Samanta; Pardo, Ricardo; Farré, Magí; O'Mahony, Brian; Torrens, Marta; Mustata, Cristina; Pérez-Mañá, Clara; Carbó, Marcel·lí; >Rafael de la Torre,

Simulation of Human Intravenous and Oral Pharmacokinetics of 21 Diverse Compounds Using Physiologically Based Pharmacokinetic Modelling
pp. 331-347(17)
Authors: Jones, Hannah M.; Gardner, Iain B.; Collard, Wendy T.; Stanley, Phil J.; Oxley, Penny; Hosea, Natilie A.; Plowchalk, David; Gernhardt, Steve; Lin, Jing; Dickins, Maurice; Rahavendran, S. Ravi; Jones, Barry C.; Watson, Kenny J.; Pertinez, Henry; Kumar, Vikas; Cole, Susan